1045: Think Cefepime Has a Mortality Benefit Over Pip-Taz? Not So Fast Say These Authors…

episode

The Elective Rotation: A Critical Care Hospital Pharmacy Podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

recent transcribed audio

Win Brooke's Bucks (9/23/26) 7 min · 23 Sep 2026 · Brooke and Jeffrey

2026-09-23- KSR - Hour 2 51 min · 23 Sep 2026 · KSR

Kevin Harlan Is As Good As Anyone In Football | Hour 2 36 min · 23 Sep 2026 · The Dan Le Batard Show

12PM ET 09/23/2026 Newscast 3 min · 23 Sep 2026 · Fox News Hourly Update

2026-09-23- KSR - Hour 1 51 min · 23 Sep 2026 · KSR

JTP: Building for 2027, Red Sox/Yankees & Postseason Races 1h 39m · 23 Sep 2026 · Blue Jays Talk

Report any issue

Source

Recorded21 Jul 2025

Publisherpharmacyjoe.com ↗

Handlerec:14529539

Show notes

Show notes at pharmacyjoe.com/episode1045. In this episode, I’ll discuss possible design flaws in a recent study that suggested cefepime has a mortality benefit over piperacillin-tazobactam.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related